Skip to main content
Medicine LibreTexts

2.10: Chapter 2 References

  • Page ID
    88373
  • \( \newcommand{\vecs}[1]{\overset { \scriptstyle \rightharpoonup} {\mathbf{#1}} } \)

    \( \newcommand{\vecd}[1]{\overset{-\!-\!\rightharpoonup}{\vphantom{a}\smash {#1}}} \)

    \( \newcommand{\id}{\mathrm{id}}\) \( \newcommand{\Span}{\mathrm{span}}\)

    ( \newcommand{\kernel}{\mathrm{null}\,}\) \( \newcommand{\range}{\mathrm{range}\,}\)

    \( \newcommand{\RealPart}{\mathrm{Re}}\) \( \newcommand{\ImaginaryPart}{\mathrm{Im}}\)

    \( \newcommand{\Argument}{\mathrm{Arg}}\) \( \newcommand{\norm}[1]{\| #1 \|}\)

    \( \newcommand{\inner}[2]{\langle #1, #2 \rangle}\)

    \( \newcommand{\Span}{\mathrm{span}}\)

    \( \newcommand{\id}{\mathrm{id}}\)

    \( \newcommand{\Span}{\mathrm{span}}\)

    \( \newcommand{\kernel}{\mathrm{null}\,}\)

    \( \newcommand{\range}{\mathrm{range}\,}\)

    \( \newcommand{\RealPart}{\mathrm{Re}}\)

    \( \newcommand{\ImaginaryPart}{\mathrm{Im}}\)

    \( \newcommand{\Argument}{\mathrm{Arg}}\)

    \( \newcommand{\norm}[1]{\| #1 \|}\)

    \( \newcommand{\inner}[2]{\langle #1, #2 \rangle}\)

    \( \newcommand{\Span}{\mathrm{span}}\) \( \newcommand{\AA}{\unicode[.8,0]{x212B}}\)

    \( \newcommand{\vectorA}[1]{\vec{#1}}      % arrow\)

    \( \newcommand{\vectorAt}[1]{\vec{\text{#1}}}      % arrow\)

    \( \newcommand{\vectorB}[1]{\overset { \scriptstyle \rightharpoonup} {\mathbf{#1}} } \)

    \( \newcommand{\vectorC}[1]{\textbf{#1}} \)

    \( \newcommand{\vectorD}[1]{\overrightarrow{#1}} \)

    \( \newcommand{\vectorDt}[1]{\overrightarrow{\text{#1}}} \)

    \( \newcommand{\vectE}[1]{\overset{-\!-\!\rightharpoonup}{\vphantom{a}\smash{\mathbf {#1}}}} \)

    \( \newcommand{\vecs}[1]{\overset { \scriptstyle \rightharpoonup} {\mathbf{#1}} } \)

    \( \newcommand{\vecd}[1]{\overset{-\!-\!\rightharpoonup}{\vphantom{a}\smash {#1}}} \)

    \(\newcommand{\avec}{\mathbf a}\) \(\newcommand{\bvec}{\mathbf b}\) \(\newcommand{\cvec}{\mathbf c}\) \(\newcommand{\dvec}{\mathbf d}\) \(\newcommand{\dtil}{\widetilde{\mathbf d}}\) \(\newcommand{\evec}{\mathbf e}\) \(\newcommand{\fvec}{\mathbf f}\) \(\newcommand{\nvec}{\mathbf n}\) \(\newcommand{\pvec}{\mathbf p}\) \(\newcommand{\qvec}{\mathbf q}\) \(\newcommand{\svec}{\mathbf s}\) \(\newcommand{\tvec}{\mathbf t}\) \(\newcommand{\uvec}{\mathbf u}\) \(\newcommand{\vvec}{\mathbf v}\) \(\newcommand{\wvec}{\mathbf w}\) \(\newcommand{\xvec}{\mathbf x}\) \(\newcommand{\yvec}{\mathbf y}\) \(\newcommand{\zvec}{\mathbf z}\) \(\newcommand{\rvec}{\mathbf r}\) \(\newcommand{\mvec}{\mathbf m}\) \(\newcommand{\zerovec}{\mathbf 0}\) \(\newcommand{\onevec}{\mathbf 1}\) \(\newcommand{\real}{\mathbb R}\) \(\newcommand{\twovec}[2]{\left[\begin{array}{r}#1 \\ #2 \end{array}\right]}\) \(\newcommand{\ctwovec}[2]{\left[\begin{array}{c}#1 \\ #2 \end{array}\right]}\) \(\newcommand{\threevec}[3]{\left[\begin{array}{r}#1 \\ #2 \\ #3 \end{array}\right]}\) \(\newcommand{\cthreevec}[3]{\left[\begin{array}{c}#1 \\ #2 \\ #3 \end{array}\right]}\) \(\newcommand{\fourvec}[4]{\left[\begin{array}{r}#1 \\ #2 \\ #3 \\ #4 \end{array}\right]}\) \(\newcommand{\cfourvec}[4]{\left[\begin{array}{c}#1 \\ #2 \\ #3 \\ #4 \end{array}\right]}\) \(\newcommand{\fivevec}[5]{\left[\begin{array}{r}#1 \\ #2 \\ #3 \\ #4 \\ #5 \\ \end{array}\right]}\) \(\newcommand{\cfivevec}[5]{\left[\begin{array}{c}#1 \\ #2 \\ #3 \\ #4 \\ #5 \\ \end{array}\right]}\) \(\newcommand{\mattwo}[4]{\left[\begin{array}{rr}#1 \amp #2 \\ #3 \amp #4 \\ \end{array}\right]}\) \(\newcommand{\laspan}[1]{\text{Span}\{#1\}}\) \(\newcommand{\bcal}{\cal B}\) \(\newcommand{\ccal}{\cal C}\) \(\newcommand{\scal}{\cal S}\) \(\newcommand{\wcal}{\cal W}\) \(\newcommand{\ecal}{\cal E}\) \(\newcommand{\coords}[2]{\left\{#1\right\}_{#2}}\) \(\newcommand{\gray}[1]{\color{gray}{#1}}\) \(\newcommand{\lgray}[1]{\color{lightgray}{#1}}\) \(\newcommand{\rank}{\operatorname{rank}}\) \(\newcommand{\row}{\text{Row}}\) \(\newcommand{\col}{\text{Col}}\) \(\renewcommand{\row}{\text{Row}}\) \(\newcommand{\nul}{\text{Nul}}\) \(\newcommand{\var}{\text{Var}}\) \(\newcommand{\corr}{\text{corr}}\) \(\newcommand{\len}[1]{\left|#1\right|}\) \(\newcommand{\bbar}{\overline{\bvec}}\) \(\newcommand{\bhat}{\widehat{\bvec}}\) \(\newcommand{\bperp}{\bvec^\perp}\) \(\newcommand{\xhat}{\widehat{\xvec}}\) \(\newcommand{\vhat}{\widehat{\vvec}}\) \(\newcommand{\uhat}{\widehat{\uvec}}\) \(\newcommand{\what}{\widehat{\wvec}}\) \(\newcommand{\Sighat}{\widehat{\Sigma}}\) \(\newcommand{\lt}{<}\) \(\newcommand{\gt}{>}\) \(\newcommand{\amp}{&}\) \(\definecolor{fillinmathshade}{gray}{0.9}\)

    Academy of Managed Care Pharmacy. (2019, July 18). Medication errors. https://www.amcp.org/about/managed-care-pharmacy-101/concepts-managed-care-pharmacy/medication-errors

    Alhayek. S. & Preuss, C. V. (2022, August 8). Beta 1 receptors. In StatPearls. https://www.ncbi.nlm.nih.gov/books/NBK532904/

    Bassett, S. M., Schuette, S. A., O'Dwyer, L. C., & Moskowitz, J. T. (2019, August 1). Positive affect and medication adherence in chronic conditions: A systematic review. Health Psychology, 38(11), 960–974. https://doi.org/10.1037/hea0000778

    Choi, J. H., & Ko, C. M. (2017, January 31). Food and drug interactions. Journal of Lifestyle Medicine, 7(1), 1–9. https://doi.org/10.15280/jlm.2017.7.1.1

    Delgado, B. J., Safadi, A. O., & Bajaj, T. (2022, July 5). Clark’s Rule. In StatPearls. https://www.ncbi.nlm.nih.gov/books/NBK541104/

    Grogan, S. & Preuss, C. (2022, June 23). Pharmacokinetics. In StatPearls. https://www.ncbi.nlm.nih.gov/books/NBK557744/

    Hallare, J. & Gerriets, V. (2022, June 23). Half life. In StatPearls. https://www.ncbi.nlm.nih.gov/books/NBK554498/

    Hanson A., Haddad L.M. (2022, September 5). Nursing rights of medication administration. StatPearls. https://www.ncbi.nlm.nih.gov/books/NBK560654/

    Institute for Safe Medication Practices. (2021, September 30). High-alert medications in community/ambulatory settings. https://www.ismp.org/recommendations/high-alert-medications-community-ambulatory-list

    Khalil, H. & Zeltser, R. (2023, May 8). Antihypertensive medications. In StatPearls. https://www.ncbi.nlm.nih.gov/books/NBK554579

    Kurt, M., Akdeniz, M., & Kavukcu, E. (2019, September 6). Assessment of comorbidity and use of prescription and nonprescription drugs in patients above 65 years attending family medicine outpatient clinics. Gerontology & Geriatric Medicine, 5, 2333721419874274. https://doi.org/10.1177/2333721419874274

    Leheny, S. (2017, February 22). "Adverse event" not the same as "side effect." Pharmacy Times. https://www.pharmacytimes.com/view/adverse-event-not-the-same-as-side-effect

    MedlinePlus (2021, September 16). Therapeutic drug monitoring. Available from: https://medlineplus.gov/lab-tests/therapeutic-drug-monitoring/

    MedlinePlus (2022, March 22). What is pharmacogenomics? Available from: https://medlineplus.gov/genetics/understanding/genomicresearch/pharmacogenomics/

    Miniaci, A. & Gupta, V. (2022, June 23). Loading dose. In StatPearls. https://www.ncbi.nlm.nih.gov/books/NBK557418/

    Murphy, P. B., Bechmann, S., & Barrett, M. J. (2023, May 22). Morphine. In StatPearls. https://www.ncbi.nlm.nih.gov/books/NBK526115/

    National Cancer Institute. (n.d.). Synergistic. In NIC dictionaries—Dictionary of cancer terms. Retrieved June 10, 2023, https://www.cancer.gov/publications/dictionaries/cancer-terms/def/synergistic

    National Coordinating Council for Medication Error Reporting and Prevention (2023). About medication errors. Retrieved September 25, 2023, from https://www.nccmerp.org/about-medication-errors

    National Institutes of Health. (2021, March 29). Vitamin K: Fact sheet for health professionals. Office of Dietary Supplements. https://ods.od.nih.gov/factsheets/VitaminK-HealthProfessional/

    Pan, S. D., Zhu, L. L., Chen, M., Xia, P., & Zhou, Q. (2016). Weight-based dosing in medication use: What should we know? Patient Preference and Adherence, 10, 549–560. https://doi.org/10.2147/PPA.S103156

    Patel, S., Singh, R., Preuss, C. V., Patel, N. (2023, March 24). Warfarin. In StatPearls. https://www.ncbi.nlm.nih.gov/books/NBK470313/

    Rodziewicz T.L., Houseman B., Hipskind J.E. (2023, May 2). Medical error reduction and prevention. In: StatPearls. https://www.ncbi.nlm.nih.gov/books/NBK499956/

    Therapeutic Research Center (2019). Potentially harmful drugs in the elderly: Beers list [Clinical Resource #350301]. https://www.pharmacyquality.com/wp-content/uploads/2019/05/Beers-List-350301.pdf

    U. S. Food and Drug Administration. (2019a, April 12). Understanding sex differences at FDA. https://www.fda.gov/science-research/womens-health-research/understanding-sex-differences-fda

    World Health Organization. (2023). ATC-DDD Toolkit: Defined daily dose. https://www.who.int/tools/atc-ddd-toolkit/about-ddd

    World Health Organization. (2023, September 11). Patient safety. https://www.who.int/news-room/fact-sheets/detail/patient-safety


      This page titled 2.10: Chapter 2 References is shared under a CC BY 4.0 license and was authored, remixed, and/or curated by Anna Jannak (Consortium of Academic and Research Libraries in Illinois (CARLI)) .

      • Was this article helpful?